ALTEOGEN
Blood & Organ Banks · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
62 Yuseong-daero 1628beon-Gil Yuseong-gu...Phone Number
+82 423848780Website
www.alteogen.comRevenue
$5.7 MillionStock Symbol
196170Industry
About ALTEOGEN
Alteogen lnc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-Drug Conjugates (ADCs), biobetters and biosimilars. Alteogen's portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP-fusion and NexMab platform technology, respectively. It is also developing Eylea biosimilar. The company was founded in 2008 and listed in KOSDAQ (196170.KQ).Explore more
ALTEOGEN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
ALTEOGEN Tech Stack
A closer look at the technologies used by ALTEOGEN
See more technologies
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ALTEOGEN
Sign Up For FreeTo access detailed company insights
Alteogen lnc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-Drug Conjugates (ADCs), biobetters and biosimilars. Alteogen's portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP-fusion and Ne... Read More
